Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Valderilio F, Azevedo"'
Autor:
Lihi Eder, Pascal Richette, Laura C. Coates, Valderilio F. Azevedo, Joseph C. Cappelleri, Edward P. Johnson, Megan Hoang, Jade Moser, Meriem Kessouri
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1115-1134 (2024)
Abstract Introduction We evaluated the impact of gender on disease severity, health-related quality of life (HRQoL), treatment management, and patient–healthcare professional (HCP) interactions from the perspectives of patients with psoriatic arthr
Externí odkaz:
https://doaj.org/article/a136d5dcae76407db3943fc986faac04
Autor:
Gerd R. Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F. Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S. Gensler
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 737-753 (2024)
Abstract Introduction This integrated analysis of the phase 2/3 and phase 3 SELECT trials describes the safety profile of upadacitinib, an oral Janus kinase inhibitor, for up to 5 years of exposure across psoriatic arthritis (PsA), ankylosing spondyl
Externí odkaz:
https://doaj.org/article/e351d86bf89749d7bfde8d923d44f476
Autor:
Gustavo Citera, Wilson Bautista-Molano, Ingris Peláez-Ballestas, Valderilio F. Azevedo, Risto A. Perich, José A. Méndez-Rodríguez, Mariel S. Cutri, Cecilia E. Borlenghi
Publikováno v:
Advances in Rheumatology, Vol 61, Iss 1, Pp 1-12 (2021)
Abstract Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on availab
Externí odkaz:
https://doaj.org/article/275bce2f61c94b41a28f0aa6ab2da5e1
Autor:
Lucas Guillo, Maria Abreu, Remo Panaccione, William J Sandborn, Valderilio F Azevedo, Lianne Gensler, Bahar Moghaddam, Vineet Ahuja, Sabrina A Ali, Matthieu Allez, Ashwin N Ananthakrishnan, Abhik Bhattacharya, Marla Dubinsky, Anne Griffiths, Ailsa Hart, Burton Korelitz, Paulo G Kotze, Ioannis E Koutroubakis, Peter L Lakatos, James O Lindsay, Fernando Magro, Gerassimos J Mantzaris, Siew C Ng, Colm O'Morain, Julian Panés, Tommaso Parigi, Zhihua Ran, Gerhard Rogler, David T Rubin, David B Sachar, Britta Siegmund, Flavio Steinwurz, Curt Tysk, Stephan Vavricka, Sofia G Verstraete, Antoine P Brezin, Anna K Haemel, Axel Dignass, Bruce E Sands, Silvio Danese, Laurent Peyrin-Biroulet
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:254-261
Extraintestinal manifestations occur frequently in patients with inflammatory bowel disease (IBD) and remain a diagnostic and therapeutic challenge. The aim of the Endpoints for Extraintestinal Manifestations in Inflammatory Bowel Disease Trials (EXT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803619801073a456b84fbe5824bfe63e
https://doi.org/10.1016/s2468-1253(21)00297-1
https://doi.org/10.1016/s2468-1253(21)00297-1
Autor:
Kevin L, Winthrop, Yoshiya, Tanaka, Eun Bong, Lee, Jürgen, Wollenhaupt, Ahmad, Al Enizi, Valderilio F, Azevedo, Jeffrey R, Curtis
Publikováno v:
Clinical and Experimental Rheumatology. 40:162-172
The risk of herpes zoster (HZ) and HZ-related complications is increased in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) relative to the general population; therefore, HZ vaccination is recommended in these patient groups. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef3cdde8ba845faa47d244a043f90aba
https://doi.org/10.55563/clinexprheumatol/cpu6r9
https://doi.org/10.55563/clinexprheumatol/cpu6r9
Autor:
Ara Dikranian, David Gold, Louis Bessette, Peter Nash, Valderilio F. Azevedo, Lisy Wang, John Woolcott, Andrea B. Shapiro, Annette Szumski, Dona Fleishaker, Jürgen Wollenhaupt
Publikováno v:
Rheumatology and Therapy. 9:411-433
Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA). This post hoc analysis assessed frequency or duration of early select non-serious adverse events (AEs; excluding infections),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0c595f4cde4cf75df392de3276e724
https://doi.org/10.1007/s40744-021-00405-w
https://doi.org/10.1007/s40744-021-00405-w
Autor:
Angela P Duarte, Cláudia DL Marques, Adriana B Bortoluzzo, Célio R Gonçalves, José Antonio Braga da Silva, Antonio Carlos Ximenes, Manoel B Bértolo, Sandra Lúcia E Ribeiro, Mauro Keiserman, Thelma L Skare, Sueli Carneiro, Rita Menin, Valderilio F Azevedo, Walber P Vieira, Elisa N Albuquerque, Washington A Bianchi, Rubens Bonfiglioli, Cristiano Campanholo, Hellen MS Carvalho, Izaias P Costa, Charles L Kohem, Nocy Leite, Sonia AL Lima, Eduardo S Meirelles, Ivânio A Pereira, Marcelo M Pinheiro, Elizandra Polito, Gustavo G Resende, Francisco Airton C Rocha, Mittermayer B Santiago, Maria de Fátima LC Sauma, Valéria Valim, Percival D Sampaio Barros
Publikováno v:
Revista Brasileira de Reumatologia, Vol 54, Iss 6, Pp 424-430 (2014)
Objetivo Analisar as características clínicas e epidemiológicas das espondiloartrites (EpA) de início juvenil (< 16 anos) e compará-las com um grupo de pacientes com EspA de início na vida adulta (≥ 16 anos). Pacientes e métodos Coorte prosp
Externí odkaz:
https://doaj.org/article/517b537df42d414ba6403bdf0068b9aa
Autor:
Pascal Richette, Laura C. Coates, Valderilio F. Azevedo, Joseph C. Cappelleri, Jade Moser, Ruben Queiro-Silva, Lara Fallon, Meriem Kessouri
To compare perceptions of disease control and treatment satisfaction between patients with psoriatic arthritis (PsA) in North America and Europe, and between participating countries within each region.Data were collected from patients with self-repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904aedccc02de37a33e735d4a833769f
https://doi.org/10.1007/s40744-022-00435-y
https://doi.org/10.1007/s40744-022-00435-y
Autor:
Gerd R. Burmester, Kevin Winthrop, Ricardo Blanco, Peter Nash, Philippe Goupille, Valderilio F. Azevedo, Carlo Salvarani, Andrea Rubbert-Roth, Elizabeth Lesser, Ralph Lippe, Apinya Lertratanakul, Reva M. Mccaskill, John Liu, Eric M. Ruderman
Publikováno v:
Rheumatology and Therapy
Introduction This integrated analysis describes the safety profile of upadacitinib, an oral Janus kinase inhibitor, at 15 and 30 mg once daily for up to 3 years of exposure in patients with active psoriatic arthritis (PsA) who had a prior inadequate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a92e6a9cf37feb42c1ffc1a9df5498d0
https://hdl.handle.net/11380/1280559
https://hdl.handle.net/11380/1280559
Autor:
Citera, Gustavo, Bautista-Molano, Wilson, Ingris Peláez-Ballestas, Valderilio F. Azevedo, Perich, Risto A., Méndez-Rodríguez, José A., Cutri, Mariel S., Borlenghi, Cecilia E.
Additional file 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::225b94bb0fd42138b055c45a0020429f